A preliminary study on metabonomics of amino acid and glucose in patients with gallbladder stones based on nuclear magnetic resonance_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

MA Wenjie ¹ , CHEN Weiwei ² , YANG Qin ¹ ,  LI Quansheng ¹ , LI Fuyu ¹

1. Department of Biliary Surgery, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
2. Department of Pancreatic Surgery, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;

Corresponding?author：

LI Quansheng, Email: 269371698@qq.com

Keywords：

gallbladder stones; nuclear magnetic resonance; metabonomics; serum; bile

DOI：

10.7507/1007-9424.201709077

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective The method of metabonomics based on nuclear magnetic resonance (NMR) imaging was used to explore the difference in metabolites of serum and bile, and to analyze the metabolic variation related to the pathogenesis of gallbladder stones between normal people/liver transplantation donors and patients with gallbladder stones. Methods Prospectively collected the serum samples (17 cases) and bile samples (19 cases) in 19 patients with gallbladder stones who underwent surgery in West China Hospital form March 2016 to December 2016, as well as the serum samples of 10 healthy persons and the bile samples of 15 liver transplantation donors at the same time period. The differences of metabolites in the blood and bile in these 3 groups were compared by using ¹H-NMR metabonomics technology and chemometric methods. Results The concentrations of valine, alanine, lysine, glutamine, glutamate, pyruvate, creatinine, choline, alpha-glucose, beta-glucose, tyrosine, histidine, and hypoxanthine in serum of patients with gallbladder stones decreased significantly, comparing with those of healthy people without gallbladder stones (P<0.05), while 1, 2-propanediol, acetoacetate, and lactate increased significantly in the serum of patients with gallbladder stones (P<0.05). The concentrations of taurine conjugated bile acids, glycine conjugated bile acids, choline, and phosphatidylcholine decreased significantly in the bile of patients with gallbladder stones when compared with those of liver transplantation donors (P<0.05), while cholesterol increased significantly in the bile of patients with gallbladder stones (P<0.05). Conclusions There are significant differences of the serum and bile metabolites between patients with gallbladder stones and healthy men without gallbladder stones/liver transplantation donors. ¹H-NMR metabonomics is helpful to investigate the pathogenesis of gallbladder stones.

Citation： MA Wenjie, CHEN Weiwei, YANG Qin, LI Quansheng, LI Fuyu. A preliminary study on metabonomics of amino acid and glucose in patients with gallbladder stones based on nuclear magnetic resonance. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2018, 25(4): 401-409. doi: 10.7507/1007-9424.201709077 Copy

1.	劉清, 金俊哲, 呂洪洋, 等. 膽囊結石的相關危險因素分析. 中國普外基礎與臨床雜志, 2016, 23(12): 1492-1495.
2.	吳大衛. 膽囊結石成因及其相關關系研究綜述. 醫學信息 (中旬刊), 2011, 24(8): 4124-4125.
3.	Gurusamy KS, Davidson BR. Gallstones. BMJ, 2014, 348: g2669.
4.	汪小輝, 鄧俠興, 祝哲誠, 等. 從膽石成因機制分析膽囊切除術治療膽石病. 肝膽胰外科雜志, 2011, 23(1): 41-42.
5.	李彥東, 吳琪. 代謝組學技術在臨床診斷中的研究進展. 天津醫藥, 2015, 43(8): 942-945.
6.	江春迎, 王映紅. 基于核磁共振技術的定量代謝組學研究. 藥學學報, 2014, 49(7): 949-955.
7.	Holmes E, Wijeyesekera A, Taylor-Robinson SD, et al. The promise of metabolic phenotyping in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol, 2015, 12(8): 458-471.
8.	Kimhofer T, Fye H, Taylor-Robinson S, et al. Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review. Br J Cancer, 2015, 112(7): 1141-1156.
9.	Murakami Y, Kubo S, Tamori A, et al. Comprehensive analysis of transcriptome and metabolome analysis in intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Sci Rep, 2015, 5: 16294.
10.	譚宜將, 劉衍民. 膽囊結石發病原因研究現狀與進展. 中國實用外科雜志, 2009, 29(7): 602-603, 606.
11.	李瑞斌, 李艷茹, 萬智恒, 等. 膽囊結石的形成原因及機制. 世界最新醫學信息文摘 (電子版), 2015, 15(23): 39.
12.	周輝芳, 張曉玲, 史美瑗. 膽囊結石病因與致石疾病研究進展. 河北醫科大學學報, 2010, 31(8): 1029-1032.
13.	Behar J, Mawe GM, Carey MC. Roles of cholesterol and bile salts in the pathogenesis of gallbladder hypomotility and inflammation: cholecystitis is not caused by cystic duct obstruction. Neurogastroenterol Motil, 2013, 25(4): 283-290.
14.	Wasinski F, Gregnani MF, Ornellas FH, et al. Lymphocyte glucose and glutamine metabolism as targets of the anti-inflammatory and immunomodulatory effects of exercise. Mediators Inflamm, 2014, 2014: 326803.
15.	Sharma RK, Mishra K, Farooqui A, et al. ¹H nuclear magnetic resonance (NMR)-based serum metabolomics of human gallbladder inflammation. Inflamm Res, 2017, 66(1): 97-105.
16.	唐乾利, 黃欣, 俞淵, 等. 兔膽石癥的代謝組學特征及大黃靈仙膠囊的干預作用. 醫藥導報, 2013, 32(12): 1538-1542.
17.	Li FY, Cheng NS, Mao H, et al. Significance of controlling chronic proliferative cholangitis in the treatment of hepatolithiasis. World J Surg, 2009, 33(10): 2155-2160.
18.	Su Y, Wu S, Fan Y, et al. The preliminary experimental and clinical study of the relationship between the pigment gallstone and intestinal mucosal barrier. J Gastroenterol Hepatol, 2009, 24(8): 1451-1456.
19.	Tanaka S. Physiological function mediated by histamine synthesis. Yakugaku Zasshi, 2003, 123(7): 547-559.
20.	Watanabe M, Suliman ME, Qureshi AR, et al. Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality. Am J Clin Nutr, 2008, 87(6): 1860-1866.
21.	Lee YT, Hsu CC, Lin MH, et al. Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation. Eur J Pharmacol, 2005, 513(1-2): 145-150.
22.	Son DO, Satsu H, Shimizu M. Histidine inhibits oxidative stress- and TNF-alpha-induced interleukin-8 secretion in intestinal epithelial cells. FEBS Lett, 2005, 579(21): 4671-4677.
23.	Liu Y, Wang X, Hu CA. Therapeutic potential of amino acids in inflammatory bowel disease. Nutrients, 2017, 9(9): 18.
24.	Stifel FB, Herman RH. Is histidine an essential amino acid in man? Am J Clin Nutr, 1972, 25(2): 182-185.
25.	Khovidhunkit W, Kim MS, Memon RA, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res, 2004, 45(7): 1169-1196.
26.	Müller O, Schalla C, Scheibner J, et al. Expression of liver plasma membrane transporters in gallstone-susceptible and gallstone-resistant mice. Biochem J, 2002, 361(Pt 3): 673-679.
27.	俞淵, 唐乾利, 黃欣, 等. 大黃靈仙膠囊防治兔膽石病的代謝組學及超微病理研究. 中華中醫藥雜志, 2013, 28(11): 3359-3362.
28.	Tazuma S, Kanno K, Sugiyama A, et al. Nutritional factors (nutritional aspects) in biliary disorders: bile acid and lipid metabolism in gallstone diseases and pancreaticobiliary maljunction. J Gastroenterol Hepatol, 2013, 28 Suppl 4: 103-107.
29.	O’Connell K, Brasel K. Bile metabolism and lithogenesis. Surg Clin North Am, 2014, 94(2): 361-375.

1. 劉清, 金俊哲, 呂洪洋, 等. 膽囊結石的相關危險因素分析. 中國普外基礎與臨床雜志, 2016, 23(12): 1492-1495.
2. 吳大衛. 膽囊結石成因及其相關關系研究綜述. 醫學信息 (中旬刊), 2011, 24(8): 4124-4125.
3. Gurusamy KS, Davidson BR. Gallstones. BMJ, 2014, 348: g2669.
4. 汪小輝, 鄧俠興, 祝哲誠, 等. 從膽石成因機制分析膽囊切除術治療膽石病. 肝膽胰外科雜志, 2011, 23(1): 41-42.
5. 李彥東, 吳琪. 代謝組學技術在臨床診斷中的研究進展. 天津醫藥, 2015, 43(8): 942-945.
6. 江春迎, 王映紅. 基于核磁共振技術的定量代謝組學研究. 藥學學報, 2014, 49(7): 949-955.
7. Holmes E, Wijeyesekera A, Taylor-Robinson SD, et al. The promise of metabolic phenotyping in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol, 2015, 12(8): 458-471.
8. Kimhofer T, Fye H, Taylor-Robinson S, et al. Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review. Br J Cancer, 2015, 112(7): 1141-1156.
9. Murakami Y, Kubo S, Tamori A, et al. Comprehensive analysis of transcriptome and metabolome analysis in intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Sci Rep, 2015, 5: 16294.
10. 譚宜將, 劉衍民. 膽囊結石發病原因研究現狀與進展. 中國實用外科雜志, 2009, 29(7): 602-603, 606.
11. 李瑞斌, 李艷茹, 萬智恒, 等. 膽囊結石的形成原因及機制. 世界最新醫學信息文摘 (電子版), 2015, 15(23): 39.
12. 周輝芳, 張曉玲, 史美瑗. 膽囊結石病因與致石疾病研究進展. 河北醫科大學學報, 2010, 31(8): 1029-1032.
13. Behar J, Mawe GM, Carey MC. Roles of cholesterol and bile salts in the pathogenesis of gallbladder hypomotility and inflammation: cholecystitis is not caused by cystic duct obstruction. Neurogastroenterol Motil, 2013, 25(4): 283-290.
14. Wasinski F, Gregnani MF, Ornellas FH, et al. Lymphocyte glucose and glutamine metabolism as targets of the anti-inflammatory and immunomodulatory effects of exercise. Mediators Inflamm, 2014, 2014: 326803.
15. Sharma RK, Mishra K, Farooqui A, et al. ¹H nuclear magnetic resonance (NMR)-based serum metabolomics of human gallbladder inflammation. Inflamm Res, 2017, 66(1): 97-105.
16. 唐乾利, 黃欣, 俞淵, 等. 兔膽石癥的代謝組學特征及大黃靈仙膠囊的干預作用. 醫藥導報, 2013, 32(12): 1538-1542.
17. Li FY, Cheng NS, Mao H, et al. Significance of controlling chronic proliferative cholangitis in the treatment of hepatolithiasis. World J Surg, 2009, 33(10): 2155-2160.
18. Su Y, Wu S, Fan Y, et al. The preliminary experimental and clinical study of the relationship between the pigment gallstone and intestinal mucosal barrier. J Gastroenterol Hepatol, 2009, 24(8): 1451-1456.
19. Tanaka S. Physiological function mediated by histamine synthesis. Yakugaku Zasshi, 2003, 123(7): 547-559.
20. Watanabe M, Suliman ME, Qureshi AR, et al. Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality. Am J Clin Nutr, 2008, 87(6): 1860-1866.
21. Lee YT, Hsu CC, Lin MH, et al. Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation. Eur J Pharmacol, 2005, 513(1-2): 145-150.
22. Son DO, Satsu H, Shimizu M. Histidine inhibits oxidative stress- and TNF-alpha-induced interleukin-8 secretion in intestinal epithelial cells. FEBS Lett, 2005, 579(21): 4671-4677.
23. Liu Y, Wang X, Hu CA. Therapeutic potential of amino acids in inflammatory bowel disease. Nutrients, 2017, 9(9): 18.
24. Stifel FB, Herman RH. Is histidine an essential amino acid in man? Am J Clin Nutr, 1972, 25(2): 182-185.
25. Khovidhunkit W, Kim MS, Memon RA, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res, 2004, 45(7): 1169-1196.
26. Müller O, Schalla C, Scheibner J, et al. Expression of liver plasma membrane transporters in gallstone-susceptible and gallstone-resistant mice. Biochem J, 2002, 361(Pt 3): 673-679.
27. 俞淵, 唐乾利, 黃欣, 等. 大黃靈仙膠囊防治兔膽石病的代謝組學及超微病理研究. 中華中醫藥雜志, 2013, 28(11): 3359-3362.
28. Tazuma S, Kanno K, Sugiyama A, et al. Nutritional factors (nutritional aspects) in biliary disorders: bile acid and lipid metabolism in gallstone diseases and pancreaticobiliary maljunction. J Gastroenterol Hepatol, 2013, 28 Suppl 4: 103-107.
29. O’Connell K, Brasel K. Bile metabolism and lithogenesis. Surg Clin North Am, 2014, 94(2): 361-375.

Previous Article
小肝癌的多學科微創治療進展
Next Article
Diagnosis and treatment of undifferentiated pleomorphic sarcoma of colon

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

A preliminary study on metabonomics of amino acid and glucose in patients with gallbladder stones based on nuclear magnetic resonance

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content